AIM ImmunoTech Inc (AIM)

AIM ImmunoTech (AIM) Stock Price & Analysis


AIM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.29 - $1.38
Previous Close$0.4
Average Volume (3M)254.19K
Market Cap
Enterprise Value$19.24M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.9
Mar 31, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.43
Shares Outstanding39,690,012
10 Day Avg. Volume106,791
30 Day Avg. Volume254,189
Standard Deviation0.28
Financial Highlights & Ratios
Price to Book (P/B)0.51
Price to Sales (P/S)196.77
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-2.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue170.25
Enterprise Value/Gross Profit-26.91
Enterprise Value/Ebitda-1.35
Price Target Upside645.53% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was AIM ImmunoTech Inc’s price range in the past 12 months?
AIM ImmunoTech Inc lowest stock price was $0.29 and its highest was $1.38 in the past 12 months.
    What is AIM ImmunoTech Inc’s market cap?
    Currently, no data Available
    When is AIM ImmunoTech Inc’s upcoming earnings report date?
    AIM ImmunoTech Inc’s upcoming earnings report date is Mar 31, 2023 which is in 2 days.
      How were AIM ImmunoTech Inc’s earnings last quarter?
      AIM ImmunoTech Inc released its earnings results on Nov 15, 2022. The company reported -$0.13 earnings per share for the quarter, missing the consensus estimate of -$0.093 by -$0.037.
        Is AIM ImmunoTech Inc overvalued?
        According to Wall Street analysts AIM ImmunoTech Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does AIM ImmunoTech Inc pay dividends?
          AIM ImmunoTech Inc does not currently pay dividends.
          What is AIM ImmunoTech Inc’s EPS estimate?
          AIM ImmunoTech Inc’s EPS estimate is -$0.12.
            How many shares outstanding does AIM ImmunoTech Inc have?
            AIM ImmunoTech Inc has 48,082,275 shares outstanding.
              What happened to AIM ImmunoTech Inc’s price movement after its last earnings report?
              AIM ImmunoTech Inc reported an EPS of -$0.13 in its last earnings report, missing expectations of -$0.093. Following the earnings report the stock price went up 4.167%.
                Which hedge fund is a major shareholder of AIM ImmunoTech Inc?
                Currently, no hedge funds are holding shares in AIM


                AIM ImmunoTech Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                AIM ImmunoTech Inc

                AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Orlando, FL.


                Top 5 ETFs holding AIM

                Market Value
                Smart Score
                iShares Core S&P Total U.S. Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold AIM. The ETFs are listed according to market value of AIM within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                GeoVax Labs
                Aprea Therapeutics
                Dominari Holdings
                Enzon Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis